Thai FDA approves Pfizer COVID-19 vaccine for children aged 6 months -5 years

COVID-19 vaccine in vials with maroon caps, developed by Pfizer, are now approved for use in children aged 6 months to 5 years, with 3 injections of 3µg per dose. The vaccine is 80.3% effective at preventing COVID-19. Secretary-General of Thailand’s Food and Drug Administration (TFDA) Dr. Paisarn Dunkum said yesterday (Wednesday) that, on August 23rd, the TFDA subcommittee considering the registration of modern pharmacopoeia for humans, as a vaccine against the virus which causes COVID-19, approved the expansion of the use of Pfizer’s Comirnaty vaccine to include children aged 6 months to 5 years.